11 High Growth Healthcare Stocks to Buy Now

9. BioNTech SE (NASDAQ:BNTX)

BioNTech SE (NASDAQ:BNTX) is one of the best high growth healthcare stocks to buy now. On March 11, BMO Capital cut the price target on BioNTech SE (NASDAQ:BNTX) to $128 from $143 and reiterated an Outperform rating on the shares. The firm told investors in a research note that the company’s underwhelming 2026 COVID guide and confusing CEO departure messaging inject uncertainty ahead of BioNTech’s “major year for data”. It added that factors such as the uncertainty regarding the new leadership in light of a vast mid-to-late-stage pipeline and accelerating COVID revenue erosion give the firm pause on the stock.

BioNTech SE (NASDAQ:BNTX) also received a rating update from Morgan Stanley on March 11. The firm cut the price target on the stock to $125 from $134 and maintained an Overweight rating on the shares, telling investors that the company surprisingly announced a leadership transition in conjunction with its Q4 report. This overshadowed the fiscal Q4 results and the initial 2026 guidance. However, the firm added that it sees shares as undervalued ahead of a number of data read-outs following the selloff in the stock.

BioNTech SE (NASDAQ:BNTX) is a German biotechnology company that creates messenger RNA (mRNA) therapeutics and vaccines to address serious diseases such as cancer and infectious diseases. It specializes in developing and manufacturing immunotherapies for patient-specific approaches.